Santa Clara, CA 6/28/18—Agilent Technologies has entered into an agreement to purchase ProZyme, a provider of glycan analysis reagents, kits and standards, for an undisclosed amount. “ProZyme is a market leader and innovator in the glycan consumable space. This acquisition provides greater scale to our biopharma consumables business and enhances our value proposition by enabling complete glycan liquid chromatography and mass spectrometry workflow solutions,” stated Padraig McDonnell, vice president and general manager of Agilent’s Chemistries and Supplies Division. Based in California, ProZyme has 47 employees. In line with Agilent’s strategic aims, the acquisition builds upon the company’s consumables business, offerings for the biopharmaceutical market and workflow solutions. Agilent currently sells the AdvanceBio N-Glycan Sample Preparation kit and columns. The companies have worked together, creating a combined automated solution for n-glycan digestion, labeling and cleanup.